Try our Advanced Search for more refined results
Intellectual Property
-
January 08, 2026
DC Court Partially Trims Shein IP Suit Against Temu
A Washington, D.C., federal judge has trimmed some of fast fashion company Shein's intellectual property lawsuit against one of the companies behind e-commerce platform Temu, but kept alive claims for false advertising and trade secret theft.
-
January 08, 2026
Amici Back CoStar's Review Bid For Rival's Antitrust Claims
Technology industry coalition Chamber of Progress and other parties are urging the U.S. Supreme Court to grant commercial real estate information company CoStar's review petition for a Ninth Circuit ruling that revived a business rival's antitrust counterclaims.
-
January 08, 2026
Morgan Lewis Adds Ropes & Gray IP Expert In DC
Morgan Lewis & Bockius LLP has hired a top intellectual property attorney from Ropes & Gray LLP, who led that firm's Section 337 International Trade Commission practice and spent about 12.5 years there, Morgan Lewis announced Thursday.
-
January 07, 2026
VW Joins The Fed. Circ. Fray Over Patent Review Discretion
Volkswagen is the latest company to contest policy changes at the U.S. Patent and Trademark Office that make it harder to pursue patent challenges, telling the Federal Circuit that the agency's "unfettered discretion" to deny such challenges violates the U.S. Constitution.
-
January 07, 2026
Warner Bros. Hits Nokia With Antitrust Claims In Patent Case
Warner Bros. has fired back at Nokia's video coding patent suit against it with allegations that the Finnish company has violated antitrust law by running an "unlawful monopolization scheme" on the technology and going back on pledges to license its patents on reasonable terms.
-
January 07, 2026
11th Circ. Affirms YouTube Win Over DMCA Safe Harbor
The Eleventh Circuit on Wednesday affirmed a win for YouTube in a dispute with a movie producer, finding that the Digital Millennium Copyright Act does not require YouTube to police its site for infringing clips beyond responding to takedown notices.
-
January 07, 2026
Sonos, Wyze Labs Sued Over Wireless Encryption Patent
California-based patent assertion entity Encryptawave Technologies LLC targeted device-makers Sonos Inc. and Wyze Labs Inc. in separate lawsuits Wednesday in Seattle federal court, accusing the companies of infringing a patent related to wireless network security.
-
January 07, 2026
Biotech Co. Says HHS Infringed Patent With Moderna Vax Deal
A biotech company that developed a patented protein technology that allegedly expedited the development of Moderna's COVID-19 Spikevax vaccine sued the U.S. Department of Health and Human Services on Wednesday, claiming the feds infringed its patent through a contract to develop a vaccine with the pharma giant.
-
January 07, 2026
Colo. Knife Manufacturer Says Rival Misused Trademarks
A Colorado-based knife manufacturer accused one of its competitors in federal court Wednesday of selling products with its trademark brand name and logo without authorization.
-
January 07, 2026
Samsung Settles Wi-Fi Patent Suit Ahead Of EDTX Trial
Samsung has settled a case brought by Secure Wi-Fi LLC claiming the South Korean electronics giant's Galaxy smartphones infringed Secure's wireless network patents.
-
January 07, 2026
Athletics' Bid For TMs Ahead Of Vegas Move Denied
The Athletics Major League Baseball team, which is planning to move from California to Las Vegas in 2028, has failed to register a trademark for "Las Vegas Athletics" and "Vegas Athletics," with the U.S. Patent and Trademark Office concluding that the marks are primarily geographically descriptive.
-
January 07, 2026
Universal's 'M3GAN' Copied Filmmaker's Doll Pic, Suit Says
A low-budget filmmaker sued Universal Studios, Blumhouse Productions and the writers of "M3GAN" in California federal court Tuesday alleging the 2022 hit film bears a "striking resemblance" to his screenplay and movie "Paranormal Adoption."
-
January 07, 2026
Fed. Circ. Suggests Sepsis Test IP Needs Claim Construction
U.S. Circuit Judge Todd M. Hughes appeared largely persuaded Wednesday that a Delaware federal jury improperly engaged in post-trial claim construction when overriding Magnolia Medical Technologies Inc.'s $2 million infringement verdict, in an appeal that also had the Federal Circuit jurist thanking God that he doesn't try patent cases.
-
January 07, 2026
Amazon Stay Bid Should Fail In Patent Suit, WDTX Told
Texas-based Headwater Research LLC urged a Texas federal court not to pause its suit accusing Amazon of infringing a pair of server and wireless connection patents while the e-commerce giant challenges the patents at the Patent Trial and Appeal Board.
-
January 07, 2026
DSW Says Sony Copyright Case Filed In Interest Of Efficiency
The owner of shoe retailer DSW has told an Ohio federal court its lawsuit against Sony Music Entertainment seeking an order finding it did not infringe Sony's copyrights was not an anticipatory action but rather an effort to consolidate multiple infringement allegations into one in the interest of efficiency.
-
January 07, 2026
Fed. Circ. Faults Lower Court In Parking Patent Case
The Federal Circuit said a new trial is needed to determine if a parking lot management patent is invalid under a rule prohibiting patents for technologies that were used or were on sale for more than a year before a patent application is filed.
-
January 07, 2026
DC, New Jersey Delis Reach Deal To End Trademark Fight
Washington, D.C.-based bagel shop and deli Call Your Mother Corp. has agreed to drop a federal trademark lawsuit against a New Jersey deli after the parties reached a deal to end the case.
-
January 07, 2026
Lionel Messi Energy Drink Spat Voluntarily Dismissed
A beverage company behind the White Claw hard seltzer brand and an energy drink company co-owned by internet personalities Logan Paul and Olajide "KSI" Olatunji have agreed to drop a suit seeking a declaration of noninfringement and counterclaims alleging trade dress copying.
-
January 06, 2026
Thompson Hine Lands In Silicon Valley With IP Boutique Attys
Cleveland-based Thompson Hine LLP is expanding its California footprint, announcing Tuesday it is combining with Silicon Valley intellectual property litigation boutique Turner Boyd Seraphine LLP.
-
January 06, 2026
Bayer Targets Pfizer, Moderna, J&J For Covid Jab Royalties
Bayer wants a cut of the profits Johnson & Johnson, Moderna, Pfizer and BioNTech have reaped from sales of their COVID-19 vaccines, which the German biotech company alleges were only made possible through infringement of its intellectual property, according to lawsuits filed Tuesday in New Jersey and Delaware federal courts.
-
January 06, 2026
Ramey Blocked As Atty In Image Patent Fight In NY
Intellectual property attorney William Ramey was prevented from representing the owner of image processing and modifying patents used in special eyeglasses in an infringement suit in New York federal court, leading the company to abandon the case.
-
January 06, 2026
Envestnet Trade Secrets Suit Cleared For Trial
A Delaware federal judge has cleared the way for a long-running fintech trade secrets case to proceed toward trial, overruling defense objections to spoliation findings and holding that a jury may infer that destroyed electronic evidence would have been unfavorable to Envestnet Inc. and its former subsidiary Yodlee Inc.
-
January 06, 2026
Fed. Circ. Asks If Wrong Autel Was Sued In Nixed $6.6M IP Row
A Federal Circuit panel grappled Tuesday with a Texas federal judge's disposing of a $6.6 million infringement verdict against Autel over Orange Electronic Co.'s tire pressure monitoring patent, with one judge questioning Orange's choice of defendant in the case.
-
January 06, 2026
Atty Apologizes For ChatGPT-Hallucinated Citations In Briefs
A patent attorney has apologized to a Kansas federal judge for submitting a court filing with case citations hallucinated by ChatGPT, calling the experience "shameful and embarrassing" and saying he was in a poor mental state at the time due to his mother and aunt being hospitalized and dying shortly after.
-
January 06, 2026
Drugmakers Fight Multifront Legal Battles Over GLP-1s
In the wake of U.S. Food and Drug Administration approvals for GLP-1 weight-loss drugs, surging public demand and massive profits have inspired a broad range of drugmaker litigation against competitors, alleged counterfeits and telehealth providers.
Expert Analysis
-
How Fed. Circ. Shaped Subject Matter Eligibility In 2025
The Federal Circuit's most impactful patent eligibility decisions this year, touching on questions about obviousness and abstractness, provide a toolbox of takeaways that can be utilized during patent preparation and prosecution to guard against potential challenges, says Reilley Keane at Banner Witcoff.
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
Fed. Circ. In Oct.: Spotlight On Wording Beyond Patent Claims
The Federal Circuit's recent decision in Barrette Outdoor Living v. Fortress Iron provides useful guidance on how patent prosecutors should avoid language that triggers specification disclaimer and prosecution disclaimer, doctrines that may be used to narrow the scope of patent infringement claims, say attorneys at Knobbe Martens.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
How Large Patent Damages Awards Actually Play Out
Most large verdicts in patent infringement cases are often overturned or reduced on appeal, implying that the Federal Circuit is serving its intended purpose of correcting outlier outcomes, and that the figures that catch headlines and dominate policy debates may misrepresent economic realities, says Bowman Heiden at Berkeley School of Law.
-
How Unchecked AI Exposes Expert Opinions To Exclusion
A growing number of cases illustrate the potential for misuse of artificial intelligence tools by experts in litigation, resulting in reports with hallucinated information or unexplainable analysis, so to embrace the efficiencies AI tools introduce without falling victim to the risks, attorneys and experts should implement a few best practices, say attorneys at Willkie Farr.
-
Series
Law School's Missed Lessons: Practicing Client-Led Litigation
New litigators can better help their corporate clients achieve their overall objectives when they move beyond simply fighting for legal victory to a client-led approach that resolves the legal dispute while balancing the company's competing out-of-court priorities, says Chelsea Ireland at Cohen Ziffer.
-
Navigating 2025's Post-Grant Proceeding Shakeups
Extensive changes to the U.S. Patent Trial and Appeal Board's post-grant proceedings this year, including the new settled expectations factor and revitalization of Fintiv factors, require petitioners and patent owners alike to be mindful when selecting patents to assert and challenge, say attorneys at Quinn Emanuel.
-
Series
The Law Firm Merger Diaries: How To Build On Cultural Fit
Law firm mergers should start with people, then move to strategy: A two-level screening that puts finding a cultural fit at the pinnacle of the process can unearth shared values that are instrumental to deciding to move forward with a combination, says Matthew Madsen at Harrison.
-
Latisse Ruling's Lessons On Avoiding Chemical Patent Pitfalls
The Federal Circuit's decision in Duke v. Sandoz, reversing a $39 million infringement claim for selling a generic Latisse product, reinforces a fundamental truth in chemical patent strategy: Broad genus claims rarely survive without clear evidence of possession of specific embodiments, says Kimberly Vines at Stites & Harbison.
-
A Redirection For AIA Proceedings Under New USPTO Director
A recent U.S. Patent and Trademark Office memorandum implementing a bifurcated process for determining whether to institute an inter partes review or post-grant review, and the new director's subsequent notice of proposed rulemaking with additional limitations on the use of IPRs, may significantly affect patent litigation strategies, say attorneys at Sterne Kessler.
-
Considerations When Invoking The Common-Interest Privilege
To successfully leverage the common-interest doctrine in a multiparty transaction or complex litigation, practitioners should be able to demonstrate that the parties intended for it to apply, that an underlying privilege like attorney-client has attached, and guard against disclosures that could waive privilege and defeat its purpose, say attorneys at DLA Piper.
-
Motorola Ruling Solidifies Discretionary Authority Of USPTO
The Federal Circuit's latest ruling in In re: Motorola Solutions Inc. underscores the finality and discretionary nature of the finality of Patent Trial and Appeal Board institution decisions, and clarifies that neither interim guidance nor shifting administrative policy creates substantive rights for petitioners, say attorneys at Morgan Lewis.
-
Series
The Law Firm Merger Diaries: Making The Case To Combine
When making the decision to merge, law firm leaders must factor in strategic alignment, cultural compatibility and leadership commitment in order to build a compelling case for combining firms to achieve shared goals and long-term success, says Kevin McLaughlin at UB Greensfelder.
-
How Brand-Entertainment Collabs Are Reshaping IP Strategy
As storytelling and commerce become increasingly intertwined, brand and entertainment collaborations demand equal parts creativity and legal precision, and rightsholders that proactively align their IP, clearance and ownership strategies will be best positioned to capture opportunity while mitigating risk, says Bess Morgan at Loeb & Loeb.